Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,602 | 87 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan, Inc. | $656.53 | 40 | $0 (2021) |
| ABBVIE INC. | $312.51 | 19 | $0 (2023) |
| Adlon Therapeutics L.P. | $202.55 | 9 | $0 (2021) |
| IDORSIA PHARMACEUTICALS US INC | $120.86 | 1 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $113.71 | 6 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $54.69 | 3 | $0 (2018) |
| Takeda Pharmaceuticals U.S.A., Inc. | $40.34 | 2 | $0 (2018) |
| Ironshore Pharmaceuticals Inc. | $18.58 | 1 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $15.85 | 1 | $0 (2017) |
| Lundbeck LLC | $14.93 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $149.88 | 3 | IDORSIA PHARMACEUTICALS US INC ($120.86) |
| 2023 | $92.23 | 5 | Supernus Pharmaceuticals, Inc. ($56.18) |
| 2022 | $222.60 | 13 | ABBVIE INC. ($194.09) |
| 2021 | $192.12 | 10 | Adlon Therapeutics L.P. ($90.38) |
| 2020 | $308.57 | 21 | Allergan, Inc. ($196.40) |
| 2019 | $127.50 | 7 | Allergan Inc. ($82.20) |
| 2018 | $288.54 | 18 | Allergan Inc. ($227.59) |
| 2017 | $220.46 | 10 | Allergan Inc. ($130.97) |
All Payment Transactions
87 individual payment records from CMS Open Payments — Page 4 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/09/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: NEUROSCIENCE | ||||||
| 03/05/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.75 | General |
| Category: NEUROSCIENCE | ||||||
| 12/20/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $93.73 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $5.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/13/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.28 | General |
| Category: PSYCHIATRY | ||||||
| 09/26/2017 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $14.93 | General |
| Category: PSYCHIATRY | ||||||
| 08/15/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: NEUROSCIENCE | ||||||
| 06/12/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: NEUROSCIENCE | ||||||
| 05/18/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: Central Nervous System (CNS) | ||||||
| 05/12/2017 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: PDP | ||||||
| 04/03/2017 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: PSYCHIATRY | ||||||
| 02/06/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: NEUROSCIENCE | ||||||
About Dr. Paul Reardon, M.D
Dr. Paul Reardon, M.D is a Psychiatry healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1396951828.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Paul Reardon, M.D has received a total of $1,602 in payments from pharmaceutical and medical device companies, with $149.88 received in 2024. These payments were reported across 87 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,602).
Practice Information
- Specialty Psychiatry
- Location Newport Beach, CA
- Active Since 05/14/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1396951828
Products in Payments
- VRAYLAR (Drug) $969.04
- ADHANSIA XR (Drug) $202.55
- QUVIVIQ (Drug) $120.86
- QELBREE (Drug) $84.69
- REXULTI (Drug) $69.62
- Trintellix (Drug) $51.47
- Qelbree (Drug) $29.02
- Jornay PM 20mg capsules (Bottle of 100) (Drug) $18.58
- BELSOMRA (Drug) $15.85
- Evekeo ODT (Drug) $14.36
- NUPLAZID (Drug) $13.50
- WELLBUTRIN (Drug) $12.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Newport Beach
Dr. Nader Oskooilar, Md, MD
Psychiatry — Payments: $321,179
Dr. Hadi Estakhri, M.d, M.D
Psychiatry — Payments: $16,721
Dr. Venice Sanchez, M.d, M.D
Psychiatry — Payments: $16,294
Dr. Hisham Korraa, M.d, M.D
Psychiatry — Payments: $14,252
Dr. Stefani Lafrenierre, Md, MD
Psychiatry — Payments: $7,842
Nimisha Jain, Pa, PA
Psychiatry — Payments: $6,289